Cargando…

Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease

The Gene Ontology (GO) is widely recognised as the gold standard bioinformatics resource for summarizing functional knowledge of gene products in a consistent and computable, information-rich language. GO describes cellular and organismal processes across all species, yet until now there has been a...

Descripción completa

Detalles Bibliográficos
Autores principales: Foulger, R. E., Denny, P., Hardy, J., Martin, M. J., Sawford, T., Lovering, R. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896971/
https://www.ncbi.nlm.nih.gov/pubmed/26825309
http://dx.doi.org/10.1007/s12021-015-9293-2
_version_ 1782436058267385856
author Foulger, R. E.
Denny, P.
Hardy, J.
Martin, M. J.
Sawford, T.
Lovering, R. C.
author_facet Foulger, R. E.
Denny, P.
Hardy, J.
Martin, M. J.
Sawford, T.
Lovering, R. C.
author_sort Foulger, R. E.
collection PubMed
description The Gene Ontology (GO) is widely recognised as the gold standard bioinformatics resource for summarizing functional knowledge of gene products in a consistent and computable, information-rich language. GO describes cellular and organismal processes across all species, yet until now there has been a considerable gene annotation deficit within the neurological and immunological domains, both of which are relevant to Parkinson’s disease. Here we introduce the Parkinson’s disease GO Annotation Project, funded by Parkinson’s UK and supported by the GO Consortium, which is addressing this deficit by providing GO annotation to Parkinson’s-relevant human gene products, principally through expert literature curation. We discuss the steps taken to prioritise proteins, publications and cellular processes for annotation, examples of how GO annotations capture Parkinson’s-relevant information, and the advantages that a topic-focused annotation approach offers to users. Building on the existing GO resource, this project collates a vast amount of Parkinson’s-relevant literature into a set of high-quality annotations to be utilized by the research community.
format Online
Article
Text
id pubmed-4896971
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-48969712016-06-27 Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease Foulger, R. E. Denny, P. Hardy, J. Martin, M. J. Sawford, T. Lovering, R. C. Neuroinformatics Original Article The Gene Ontology (GO) is widely recognised as the gold standard bioinformatics resource for summarizing functional knowledge of gene products in a consistent and computable, information-rich language. GO describes cellular and organismal processes across all species, yet until now there has been a considerable gene annotation deficit within the neurological and immunological domains, both of which are relevant to Parkinson’s disease. Here we introduce the Parkinson’s disease GO Annotation Project, funded by Parkinson’s UK and supported by the GO Consortium, which is addressing this deficit by providing GO annotation to Parkinson’s-relevant human gene products, principally through expert literature curation. We discuss the steps taken to prioritise proteins, publications and cellular processes for annotation, examples of how GO annotations capture Parkinson’s-relevant information, and the advantages that a topic-focused annotation approach offers to users. Building on the existing GO resource, this project collates a vast amount of Parkinson’s-relevant literature into a set of high-quality annotations to be utilized by the research community. Springer US 2016-01-29 2016 /pmc/articles/PMC4896971/ /pubmed/26825309 http://dx.doi.org/10.1007/s12021-015-9293-2 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Foulger, R. E.
Denny, P.
Hardy, J.
Martin, M. J.
Sawford, T.
Lovering, R. C.
Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease
title Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease
title_full Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease
title_fullStr Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease
title_full_unstemmed Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease
title_short Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease
title_sort using the gene ontology to annotate key players in parkinson’s disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896971/
https://www.ncbi.nlm.nih.gov/pubmed/26825309
http://dx.doi.org/10.1007/s12021-015-9293-2
work_keys_str_mv AT foulgerre usingthegeneontologytoannotatekeyplayersinparkinsonsdisease
AT dennyp usingthegeneontologytoannotatekeyplayersinparkinsonsdisease
AT hardyj usingthegeneontologytoannotatekeyplayersinparkinsonsdisease
AT martinmj usingthegeneontologytoannotatekeyplayersinparkinsonsdisease
AT sawfordt usingthegeneontologytoannotatekeyplayersinparkinsonsdisease
AT loveringrc usingthegeneontologytoannotatekeyplayersinparkinsonsdisease